Short description
Micropharma develops biotherapeutics, diagnostics, and devices for metabolic diseases.
Description
From basic research to product development Micropharma is focused on innovation. We apply a unique approach to discover novel and commercial probiotic and enzymatic solutions for metabolic diseases.
What we do
Micropharma Limited discovers and develops bacteria as biotherapeutics for metabolic diseases. The Company uses its proprietary discovery and development platform ProSelect to screen and select bacteria capable of expressing phenotypic traits that can effectively target metabolic pathways recognized as having therapeutic potential. Micropharma then uses its novel fermentation and optimization techniques to induce over-expression of these traits.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Montréal, Quebec, Canada, North America
Founded on
January 1, 2004
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Founders
Mitchell L. Jones, Satya Prakash